Nyxoah SA Ordinary Shares (NYXH) is a publicly traded Healthcare sector company. As of August 24, 2026, NYXH trades at $1.65 with a market cap of $160.12M and a P/E ratio of 0.00. NYXH moved +3.13% today. Year to date, NYXH is -65.22%; over the trailing twelve months it is -74.80%. Its 52-week range spans $1.26 to $11.87. Analyst consensus is buy with an average price target of $4.26. Rallies surfaces NYXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NYXH news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.65 |
| Market Cap | $160.12M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.87 |
| 52-Week Low | $1.26 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NYXH: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.26.